Zhong Jifu – Trademark Portfolio

Entity Type: 01

Zhong Jifu holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 2 filings in this category. The portfolio also extends into Class 16 (Paper Goods) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include LOVWORD, ALSEXLOV, KITVACPAK, and SURPOXYLOC. The owner is based in Lianjiang, Guangdong.

No.12, Huajiao Vil.,

Hengxin Vil. Committee, Shijiao Town,

Lianjiang, Guangdong 524462 , CN

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

LOVWORD
LOVWORD
Registered 2021
ALSEXLOV
ALSEXLOV
Registered 2021
KITVACPAK
KITVACPAK
Registered 2020

Trademark Classifications

Zhong Jifu's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

16
Paper Goods (2 filings)

Paper and cardboard; printed matter; bookbinding material; photographs; stationery

Frequently Asked Questions

How many trademarks does Zhong Jifu have?

Zhong Jifu has 4 U.S. trademarks filed with the USPTO. Of these, 4 registered.

What trademark classes does Zhong Jifu file in?

Zhong Jifu files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 16 (Paper Goods). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Zhong Jifu's most well-known trademarks?

Zhong Jifu's registered trademark portfolio includes well-known marks such as LOVWORD, ALSEXLOV, KITVACPAK, and SURPOXYLOC. These are among 4 currently registered trademarks in the portfolio.

What is Zhong Jifu's trademark registration success rate?

Zhong Jifu has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.